WO2019107509A1 - Blood test container - Google Patents

Blood test container Download PDF

Info

Publication number
WO2019107509A1
WO2019107509A1 PCT/JP2018/044070 JP2018044070W WO2019107509A1 WO 2019107509 A1 WO2019107509 A1 WO 2019107509A1 JP 2018044070 W JP2018044070 W JP 2018044070W WO 2019107509 A1 WO2019107509 A1 WO 2019107509A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
blood collection
collection bottle
communication hole
blood test
Prior art date
Application number
PCT/JP2018/044070
Other languages
French (fr)
Japanese (ja)
Inventor
康雄 喜島
和彦 有岡
Original Assignee
ジャパン・メディカル・リーフ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジャパン・メディカル・リーフ株式会社 filed Critical ジャパン・メディカル・リーフ株式会社
Publication of WO2019107509A1 publication Critical patent/WO2019107509A1/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/02Devices for withdrawing samples
    • G01N1/10Devices for withdrawing samples in the liquid or fluent state
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/02Devices for withdrawing samples
    • G01N1/10Devices for withdrawing samples in the liquid or fluent state
    • G01N1/16Devices for withdrawing samples in the liquid or fluent state with provision for intake at several levels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers

Definitions

  • the present invention relates to a blood separation container used for blood tests.
  • a needle is usually inserted into a vein, a 5 cc blood is collected, the collected blood is centrifuged, the serum or plasma component is removed, and the target test item is examined. It was
  • HbA1c uses blood cell components.
  • HbA1c hemoglobin A1c reflecting the past average blood glucose level.
  • two blood samples were taken, one for collecting the plasma component and the other for collecting the blood cell component.
  • Blood collection is performed by inserting a needle into a vein. If there is nerve damage or amputation during blood collection, sequelae may remain for several months or the fingers may become inaccessible. As described above, blood collection is a risky medical procedure, and even in the case of blood collection conducted by a medical institution, it is said that there are about 100,000 medical accidents associated with blood collection annually.
  • the separation of blood with a gel-like separating agent is very difficult because the gel-like separating agent adheres to the analysis nozzle, so that the blood cell component in the lower layer is very difficult to collect.
  • the conventional blood test apparatus of this type is complicated in structure and not easy to handle.
  • the current status of blood tests is that, of the approximately 5 cc of blood collected, the blood components used for the actual test are, for example, only a few percent, and most of the blood components are discarded.
  • the discarded blood is a medical waste, there is a problem that the disposal requires a lot of management and cost.
  • the object of the present invention is to provide a blood separation container capable of performing a test based on a plasma component and a test based on a blood cell component with the same accuracy as in a conventional blood collection with one blood collection tube. I assume.
  • Another object of the present invention is to provide an easy-to-handle container for separating blood, which enables blood tests to be performed with the same accuracy as in the prior art not only by medical institutions but also by self-collecting blood.
  • the present invention further provides a blood separation container capable of reliably performing a test based on a plasma component and a test based on a blood cell component even in a necessary and sufficient amount for a blood test, that is, a small amount of blood. With the goal.
  • the present invention further aims to simultaneously achieve these.
  • the blood test container is a blood test instrument comprising a blood collection bottle and a separation float
  • the blood collection bottle comprises a bottomed cylindrical container with an open tip end
  • a separating agent is applied to the peripheral wall
  • the separation float is movably accommodated in the blood collection bottle
  • the separation float is formed with a cup portion in which a surface for receiving blood is notched in a spherical shape
  • a communication hole is provided in the portion, and the cup portion communicates with the bottom surface of the blood collection bottle through the communication hole, and the communication hole is formed by enlarging the bottom side opening surface of the blood collection bottle, and the bottom portion of the separation float is It is characterized in that it is formed in the same shape as the bottom of the blood collection bottle.
  • the cup portion is formed in a hemispherical shape. Further, in the blood test instrument according to claim 2, the cup portion has a semicircular cross section. In the blood test instrument according to claim 2, the cup portion is semi-elliptical in cross section, and the major axis is formed in the longitudinal direction of the blood collection bottle.
  • the peripheral wall of the enlarged hole of the communication hole is formed in a concave arc shape. In the blood test instrument according to any one of claims 1 to 4, the peripheral wall of the enlarged hole of the communication hole is formed in an arc shape.
  • the peripheral wall of the enlarged hole of the communication hole is formed in a flat shape.
  • the separating agent is applied in a band shape to an intermediate portion of the inner peripheral wall of the blood collection bottle.
  • an anticoagulant is applied to the inner peripheral wall of the upper portion of the blood collection bottle.
  • the separation float is initially positioned in a semi-fixed state in the middle of the blood collection bottle.
  • a blood collection nozzle is detachably fitted to the front end of the blood collection bottle, the blood collection nozzle is open at both ends, and is tapered toward the front end.
  • a pressure control groove for pressure control is formed at a proximal end portion detachably fitted to the blood collection bottle.
  • the blood plasma component 21a is separated and generated in the upper layer in the blood collection bottle, and the blood cell component 21b is separated and generated in the lower layer. Then, after collecting the plasma component 21a of the centrifuged supernatant, as shown in FIG. 5C, the blood cell component 21b is pushed up above the cup portion of the separation float through the communicating hole by depressing the separation float next. By collecting this blood cell component layer with the analysis nozzle, collection and measurement of the two components of blood become possible.
  • the blood plasma component 21a and the blood cell component 21b are reliably separated, it is possible to conduct a blood test with the same accuracy as in the conventional test, even with a small amount of blood.
  • FIG. 1 is a front view showing an embodiment of a blood separation container according to the present invention
  • B is a plan view of (A)
  • C is a cross-sectional view taken along the line CC of (A)
  • D is It is the D section enlarged view of C).
  • A) is a front view of the inspection bottle of FIG. 1
  • B is a plan view of (A)
  • C is a cross-sectional view taken along the line CC of (A)
  • (D) is a cross-section taken along line DD of (B)
  • FIG. (A) is a front view of the separation float of FIG.
  • (B) is a plan view of (A)
  • (C) is a bottom view of (A)
  • (D) is a DD sectional view of (A)
  • E) is a perspective view of (A)
  • (F) is an enlarged view of an F part of (D).
  • (A) Front view of the blood collection nozzle of FIG. 1, (B) is a bottom view of (A), (C) is a plan view of (A), (D) is a cross-sectional view taken along DD of (A), (E ) Is an EE sectional view of (B).
  • (A) is a schematic cross-sectional view of a first step showing a method of using the blood separating container according to the present invention
  • (B) is a schematic cross-sectional view of the second step
  • (C) is a schematic cross-sectional view of the third step.
  • (A) is a schematic sectional drawing which shows the example of suction of the plasma component by the container for blood separation by this invention
  • (B) is a schematic sectional drawing which shows the example of suction of the plasma component by a comparative example. It is a graph which shows correlation with finger blood and venous blood of TP. It is a graph which shows correlation with finger blood and venous blood of ALB. It is a graph which shows correlation with finger blood and venous blood of AST.
  • FIG. 1 shows a blood test device according to the present invention in which a blood collection nozzle for blood collection is incorporated.
  • Reference numeral 1 denotes a blood collection bottle, which comprises a bottomed cylindrical container in which the tip 3 is opened.
  • FIG. 2 shows the details of the blood collection bottle 1, 5 being the bottom of the blood collection bottle 1 having a concave arc shaped bottom 5a and having its proximal end extended outwardly to form a leg 5b.
  • the tip 3 is provided with a removable lid 4.
  • a separation float 7 is movably accommodated in the blood collection bottle 1.
  • FIG. 3 shows the details of the separating float 7. That is, the separation float 7 is formed on the upper surface thereof with a cup portion 9 cut in a hemispherical shape (in the illustrated embodiment, a semicircular cross section in the illustrated embodiment), and the blood 21 collected by this cup portion 9 (shown in FIG. ). Further, a communication hole 11 is provided at the central portion of the separation float 7, and the cup portion 9 and the bottom surface 5 a of the blood collection bottle 1 are communicated with each other through the communication hole 11. In the communication hole 11, the opening surface on the bottom side of the blood collection bottle 1 is enlarged, and the enlarged hole 13 is formed here. The peripheral wall 13a of the enlarged hole 13 of the communication hole 11 is formed in a concave arc shape as shown in FIG. 3 (F).
  • a gel-like separating agent 16a having a specific gravity slightly larger than that of the float 7 is initially formed in a band shape as shown in FIG. It is applied.
  • Reference numeral 17 denotes a blood collection nozzle, which is detachably fitted to the front end portion 3 of the blood collection bottle 1. As shown in FIG. 4, the blood collection nozzle 17 is open at both ends, is formed in a tapered shape toward the tip end portion 17 a, and pressure adjustment is performed on the proximal end portion 17 b detachably fitted to the blood collection bottle 1.
  • the pressure control groove 18 for the is formed.
  • the blood collection bottle 1, the separation float 7, and the blood collection nozzle 17 are all made of plastic.
  • the separation float 7 is positioned in a semi-fixed state at a longitudinally intermediate portion of the inner peripheral wall 1 b of the blood collection bottle 1 before use. This is because of the tackiness of the gel-like separating agent 16a that is initially applied.
  • blood collection nozzle 17 shown in FIG. 4 When blood collection nozzle 17 shown in FIG. 4 is used at the time of blood collection, blood collection nozzle 17 is detachably fitted to tip portion 3 of blood collection bottle 1 as shown in FIG. In this case, an anticoagulant (not shown) is sprayed on the inner peripheral wall 17c of the blood collection nozzle 17 and the upper inner peripheral wall 1a of the blood collection bottle 1, and is in a dry state at the time of use.
  • a user collects a small amount of blood from the finger of the hand with a puncture device not shown.
  • a puncture device not shown.
  • an anticoagulant is applied to the inside of the blood collection nozzle 17 and the inner surface of the blood collection bottle 1, as shown in FIG. It is transported to the blood analysis center without doing anything.
  • the gel-like separation agent 16a applied in a band shape to the inner peripheral wall 1b of the blood collection bottle 1 is inserted into the blood collection bottle 1 while rotating the separation float 7, whereby the outer peripheral wall 7a of the separation float 7 and the blood collection bottle 1 First, the space between the outer peripheral wall 7a of the separation float 7 and the inner peripheral wall 1b of the blood collection bottle 1 is sealed.
  • the blood cell component 21 b having a large specific gravity drops from the communication hole 11 to the bottom 5. At this time, due to the specific gravity difference of each part, as shown in FIG.
  • the blood plasma component 21a, the separation float 7, the separating agent 16b, and the blood cell component 21b are layered sequentially from the top.
  • the separation agent 16a entering between the outer peripheral wall 7a of the separation float 7 and the inner peripheral wall 1b of the blood collection bottle 1 by the insertion of the separation float 7 gradually falls when the end of the centrifugal separation is reached.
  • the adhesive force gathers in the central direction and finally continues to form a layered separating agent 16 b at the bottom 7 b of the separating float 7.
  • the enlarged hole 13 and the communicating hole 11 of the separation float 7 are closed by the separating agent 16 b. Due to this sealing effect, the blood plasma component 21a shown by hatching is separated and generated in the upper layer in the blood collection bottle 1, and the blood cell component 21b shown in cross hatching is separated and generated in the lower layer.
  • the separation float 7 is then pushed from the position of A (shown in FIG. 5 (B)) to the position of B (shown in FIG. 5 (C)). Since the separating agent 16b is removed into the cup portion 9 by the pressing pressure, the blood cell component 21b is pushed up above the cup portion 9 of the separation float 7 through the communication hole 11, and this blood cell component layer is subjected to the analysis nozzle 19 Collecting and measuring the two components of blood becomes possible.
  • the separated plasma component 21a is sucked by the analysis nozzle 19 and subjected to a predetermined test by an automatic analyzer (not shown). Since the blood plasma component 21a and the blood cell component 21b are completely separated at the time of this suction and there is no possibility that the blood cell component 21b is mixed in the blood plasma component 21a, the accuracy of the blood test is equivalent to that of the conventional test. Can be maintained.
  • the analysis nozzle 19 of the automatic analyzer collides with the inner peripheral surface 9a of the cup portion 9'.
  • the blood cell component 21b is mixed, so that accurate analysis can not be performed.
  • the separation float 7 is pushed down, and the blood cell component 21b of the lower layer is pushed up, so that blood cells are mixed.
  • the analysis nozzle 19 is not at the suitable position (near the center) of the cup portion 9 as shown in FIG. 5B, but the cup portion 9 as shown in FIG. Even if it is positioned at the improper position (eccentric position), the cup portion 9 is formed in a hemispherical shape, and the blood cell component 21b in the lower layer is pushed up because it is equidistant at any position of the cup portion 9. In addition, since there is no risk of contamination of the blood cell component 21b, the collection of the plasma component 21a can be made stable and reliable.
  • the separation float 7 since the inner peripheral surface 9a of the cup portion 9 is cut in a hemispherical shape, the communication hole 11 can be relatively shortened, and the blood cell component 21b can be easily collected. There is. This is because when the communication hole 11 is elongated, the pressing distance of the separation float 7 becomes longer at the time of collecting the blood cell component 21b, so that the collection of the blood cell component 21b becomes difficult.
  • the blood collection of the blood collection bottle 1 is performed by puncturing a finger with a puncture tool (not shown). Yes, there is no risk of nerve damage or amputation, and self-collection can be performed without risk.
  • the blood plasma component 21a and the blood cell component 21b are reliably separated, it is possible to conduct a blood test with the same accuracy as the conventional test, even if the blood volume is as small as about 150 ⁇ l, for example.
  • "150 ⁇ l" of blood collection is an amount securing the re-inspection.
  • ⁇ Use reagent and analyzer> A list of measurement reagents is shown in Table 1.
  • items other than HbA1c were measured by an automatic biochemical analyzer (JCA.BM6070, JEOL), and HbA1c was measured by an enzymatic method using an automatic biochemical analyzer (JCA.BM6050, JEOL).
  • Table 2 and FIGS. 7A to 7N show the correlation between the finger blood and the venous blood of each item.
  • the correlation coefficient of TP was the worst among 0.884 and 14 items, but the difference between the mean value of the finger head blood and the measured value of vein was as small as 1.3%.
  • the TP of finger blood was higher than that of venous blood. It is believed that the finger blood is plasma blood and is due to the difference in fiprinogen content. The measured value of each item converged almost on the regression line, showing very effective results, and no case was found to be misjudged.
  • the blood test according to the present invention has less error factors than the conventional method, and the analysis result is evaluated as almost equal to the medical institution data.
  • blood suction into the nozzle at the time of blood collection is extremely good and blood collection can be smoothly performed, blood collection volume is also sufficient at 150 to 200 ⁇ l, and blood plasma and blood cells can be measured from one blood collection tube.
  • the structure is simple and easy to handle, and a reliable sealing effect can be obtained in blood separation.
  • the enlarged hole 13 of the communication hole 11 can have a circumferential wall shaped like an arc or flat.
  • the application of the separating agent may be applied in the form of dots at an intermediate position of the inner peripheral wall 1 b of the blood collection bottle 1. Further, the initial position of the separation float 7 is also allowed to be changed depending on the amount of the blood plasma component 21a and the blood cell component 21b to be collected.
  • the shape of the inner peripheral wall 17c of the blood collection nozzle 17 is arbitrary, and a step (not shown) may be provided halfway.
  • the examination item of the report after paragraph 0043 is for demonstrating the high precision of a blood test, and does not limit the examination item of the instrument for a blood test by this invention.
  • the instrument for a blood test according to the present invention can be used for a blood test.

Abstract

[Problem] To perform, with the same accuracy as current tests and using blood collected once from one blood collection tube, a test based on a blood plasma component and a test based on a blood cell component, and to enable tests to be easily performed with good accuracy even when using self-collected blood. [Solution] A blood collection bottle 1 is formed from a bottomed cylindrical container with an open distal end 3, and a separating agent 15 is applied to the inner circumferential wall thereof. A separation float 7 is movably accommodated within the blood collection bottle 1, and a cup 9 obtained by spherically notching a surface that receives blood 21 is formed on the separation float 7. The center portion of the separation float 7 is provided with a communication hole 11, and the cup 9 and a bottom surface 5a of the blood collection bottle 1 are in communication with one another via the communication hole 11. A bottom-side opening surface 13 of the blood collection bottle 1 is formed by enlarging the communication hole 11. To separate the blood 21, the separating agent 15 adheres to the bottom surface of the separation float 7 and the surface of the enlarged hole 13, and the upper portion and lower portion within the blood collection bottle 1 are thus completely hermetically sealed with the separation float 7 as a boundary therebetween. Thus, two blood components can be collected and measured with high accuracy.

Description

血液検査用容器Blood test container
 本願発明は血液検査に用いる血液分離用容器に関する。 The present invention relates to a blood separation container used for blood tests.
 従来、血液検査をする場合、多くは静脈に注射針を刺し、5cc位の血液を採取し、採血された血液を遠心分離し、血清又は血漿成分を取り出し、目的とする検査項目の検査をしていた。 Conventionally, when performing a blood test, a needle is usually inserted into a vein, a 5 cc blood is collected, the collected blood is centrifuged, the serum or plasma component is removed, and the target test item is examined. It was
 健康診断の血液検査は、ほとんどの検査項目で血清、血漿成分を用いるが、HbA1cだけは血球成分を用いる。例えば、糖尿病検査のための血糖値検査では血漿成分の血糖値だけでなく、過去の平均的血糖値を反映する血球成分のHbA1c(ヘモグロビンA1c)を検査する必要がある。
 このような場合は、血漿成分を採取するための採血と、血球成分を採取するための採血との2本採血を行っていた。
Medical examination blood tests use serum and plasma components for most examination items, but only HbA1c uses blood cell components. For example, in a blood glucose level test for a diabetes test, it is necessary to test not only the blood glucose level of the plasma component but also the blood cell component HbA1c (hemoglobin A1c) reflecting the past average blood glucose level.
In such a case, two blood samples were taken, one for collecting the plasma component and the other for collecting the blood cell component.
 採血は静脈に注射針を刺して行うため、採血の際神経損傷や切断があると数か月間後遺症が残ったり、手指がきかなくなるおそれがある。
 このように、採血はリスクのある医療行為なのであり、事実医療機関で行う採血でさえ、採血に伴う医療事故が年間約10万件もあると言われている。
Blood collection is performed by inserting a needle into a vein. If there is nerve damage or amputation during blood collection, sequelae may remain for several months or the fingers may become inaccessible.
As described above, blood collection is a risky medical procedure, and even in the case of blood collection conducted by a medical institution, it is said that there are about 100,000 medical accidents associated with blood collection annually.
 一方で、医師法の改正により、現在では自己採血が適法となっている。 On the other hand, self-blood sampling is now legal due to the revision of the Doctors Act.
 ところで、血液を抗凝固剤入りの採血管で採血して放置又は遠心分離すると、血球成分が沈殿するので、上澄みに血漿成分が生成される。 By the way, when blood is collected by a blood collection tube containing an anticoagulant and left or centrifuged, blood cell components are precipitated, so that plasma components are generated in the supernatant.
 従来においては、ゲル状の分離剤での血液の分離は、分析用ノズルにゲル状の分離剤が付着してしまうため、下層の血球成分の採取が非常に困難であった。 Conventionally, the separation of blood with a gel-like separating agent is very difficult because the gel-like separating agent adheres to the analysis nozzle, so that the blood cell component in the lower layer is very difficult to collect.
 また、従来のこの種血液検査用器具は構造が複雑であり、取扱も容易でなかった。 In addition, the conventional blood test apparatus of this type is complicated in structure and not easy to handle.
 血液検査の現況の実態は、採血された5cc程度の血液のうち、実際の検査に使われる血液成分が例えば数%程度の僅少であり、大部分の血液成分が廃棄されている。しかもこの廃棄される血液は医療廃棄物となるため、廃棄に多大の管理やコストがかかるという難があった。 The current status of blood tests is that, of the approximately 5 cc of blood collected, the blood components used for the actual test are, for example, only a few percent, and most of the blood components are discarded. In addition, since the discarded blood is a medical waste, there is a problem that the disposal requires a lot of management and cost.
 このような背景及び医療費の膨大な増加が必至と言われる現在、医療機関だけでなく自己採血によっても、簡単、取扱容易で、かつ精度を維持した血液検査が求められている。 Such a background and a huge increase in medical costs are inevitable, and blood tests that are simple, easy to handle, and maintain accuracy are required not only by medical institutions but also by self-collecting blood.
特開2008-279195号公報JP 2008-279195 A
特開2008-232876号公報JP 2008-232876 A
 本願発明は、上記背景より、1本の採血管による1回の採血で血漿成分に基づく検査と血球成分に基づく検査を従来と同等の精度で行うことができる血液分離用容器を供することを目的とする。 From the above background, the object of the present invention is to provide a blood separation container capable of performing a test based on a plasma component and a test based on a blood cell component with the same accuracy as in a conventional blood collection with one blood collection tube. I assume.
 本願発明はまた、医療機関だけでなく自己採血によっても、従来と同等の精度で血液検査を行うことができ、取扱い容易な血液分離用容器を供することを目的とする。 Another object of the present invention is to provide an easy-to-handle container for separating blood, which enables blood tests to be performed with the same accuracy as in the prior art not only by medical institutions but also by self-collecting blood.
 本願発明はさらに、血液検査に必要かつ十分な量、即ち、微量な血液量であっても確実に血漿成分に基づく検査と血球成分に基づく検査とを行うことができる血液分離用容器を供することを目的とする。 The present invention further provides a blood separation container capable of reliably performing a test based on a plasma component and a test based on a blood cell component even in a necessary and sufficient amount for a blood test, that is, a small amount of blood. With the goal.
 上記課題を同時に達成することは至難であるが、本願発明はさらにまた、これらを同時に達成することをも目的とする。 Although it is extremely difficult to simultaneously achieve the above-mentioned problems, the present invention further aims to simultaneously achieve these.
 上記目的達成のため、本願発明による血液検査用容器は、採血ボトルと分離フロートとからなる血液検査用器具であって、採血ボトルは先端部が開放された有底の筒状容器からなり、内周壁に分離剤が付与されてなり、分離フロートは上記採血ボトル内に移動可能に収容され、上記分離フロートには血液を受ける面が球面状に切欠されてなるカップ部が形成されるとともに、中心部に連通孔が設けられ、該連通孔にて上記カップ部と採血ボトルの底面とが連通され、上記連通孔は採血ボトルの底部側開口面が拡大して形成され、上記分離フロートの底部は上記採血ボトルの底部と同一形状に形成されることを特徴とする。
 また、請求項1記載の血液検査用器具において、上記カップ部が半球面状に形成されることを特徴とする。
 また、請求項2記載の血液検査用器具において、上記カップ部が断面半正円形であることを特徴とする。
 また、請求項2記載の血液検査用器具において、上記カップ部が断面半楕円形であって、長軸が採血ボトルの長手方向に形成されることを特徴とする。
 また、請求項1乃至請求項4のいずれか一記載の血液検査用器具において、上記連通孔の拡大孔の周壁が凹弧状に形成されることを特徴とする。
 また、請求項1乃至請求項4のいずれか一記載の血液検査用器具において、上記連通孔の拡大孔の周壁が突弧状に形成されることを特徴とする。
 また、請求項1乃至請求項4のいずれか一記載の血液検査用器具において、上記連通孔の拡大孔の周壁が扁平状に形成されることを特徴とする。
 また、請求項1乃至請求項7のいずれか一記載の血液検査用器具において、上記分離剤が上記採血ボトルの内周壁の中間部に帯状に付与されることを特徴とする。
 また、請求項1記載の血液検査用器具において、上記採血ボトルの上部の内周壁に抗凝固剤が付与されることを特徴とする。
 また、請求項1記載の血液検査用器具において、上記分離フロートは当初上記採血ボトルの中間部に半固定状態にて位置することを特徴とする。
 また、請求項1記載の血液検査用器具において、上記採血ボトルの先端部に採血ノズルが着脱自在に嵌着され、該採血ノズルは両端が開放され、先端部に向かってテーパ状に形成され、採血ボトルに着脱自在に嵌着される基端部に、圧力調整のための圧力調整溝が形成されることを特徴とする。
In order to achieve the above object, the blood test container according to the present invention is a blood test instrument comprising a blood collection bottle and a separation float, and the blood collection bottle comprises a bottomed cylindrical container with an open tip end, A separating agent is applied to the peripheral wall, the separation float is movably accommodated in the blood collection bottle, and the separation float is formed with a cup portion in which a surface for receiving blood is notched in a spherical shape, and A communication hole is provided in the portion, and the cup portion communicates with the bottom surface of the blood collection bottle through the communication hole, and the communication hole is formed by enlarging the bottom side opening surface of the blood collection bottle, and the bottom portion of the separation float is It is characterized in that it is formed in the same shape as the bottom of the blood collection bottle.
In the blood test instrument according to claim 1, the cup portion is formed in a hemispherical shape.
Further, in the blood test instrument according to claim 2, the cup portion has a semicircular cross section.
In the blood test instrument according to claim 2, the cup portion is semi-elliptical in cross section, and the major axis is formed in the longitudinal direction of the blood collection bottle.
In the blood test instrument according to any one of claims 1 to 4, the peripheral wall of the enlarged hole of the communication hole is formed in a concave arc shape.
In the blood test instrument according to any one of claims 1 to 4, the peripheral wall of the enlarged hole of the communication hole is formed in an arc shape.
In the blood test instrument according to any one of claims 1 to 4, the peripheral wall of the enlarged hole of the communication hole is formed in a flat shape.
In the blood test instrument according to any one of claims 1 to 7, the separating agent is applied in a band shape to an intermediate portion of the inner peripheral wall of the blood collection bottle.
In the blood test instrument according to claim 1, an anticoagulant is applied to the inner peripheral wall of the upper portion of the blood collection bottle.
In the blood test instrument according to claim 1, the separation float is initially positioned in a semi-fixed state in the middle of the blood collection bottle.
In the blood test instrument according to claim 1, a blood collection nozzle is detachably fitted to the front end of the blood collection bottle, the blood collection nozzle is open at both ends, and is tapered toward the front end. A pressure control groove for pressure control is formed at a proximal end portion detachably fitted to the blood collection bottle.
 (1)1回2成分採取の効果
 血液が遠心分離されると血液の成分が上層と下層に分離され、図5(B)に示すように、分離フロートの上部に血漿成分21aが、分離フロートの下方即ち採血ボトルの底部に血球成分21bが溜まる。
 このとき、即ち血液21が血漿成分21aと血球成分21bに分離されたとき、分離剤16a、16bにより、分離フロートを境にして採血ボトル内の上部と下部が完全に密閉される。
(1) Effect of once-taken two-component collection When blood is centrifuged, the components of the blood are separated into upper and lower layers, and as shown in FIG. 5 (B), the plasma component 21a is separated at the top of the separation float. The blood cell component 21b is accumulated at the bottom of the blood collection bottle, that is, at the bottom of the blood collection bottle.
At this time, that is, when the blood 21 is separated into the plasma component 21a and the blood cell component 21b, the upper and lower portions in the blood collection bottle are completely sealed by the separating agents 16a and 16b with the separation float as a boundary.
 このシーリング効果により、採血ボトル内の上層には血漿成分21aが、下層には血球成分21bが分離生成される。そこで遠心分離した上清の血漿成分21aを採取した後、次に図5(C)に示すように、分離フロートを押し下げることにより、血球成分21bが連通孔を通じ分離フロートのカップ部の上方に押し上げられ、この血球成分層を分析用ノズルで採取することで、血液2成分の採取測定が可能となる。 Due to this sealing effect, the blood plasma component 21a is separated and generated in the upper layer in the blood collection bottle, and the blood cell component 21b is separated and generated in the lower layer. Then, after collecting the plasma component 21a of the centrifuged supernatant, as shown in FIG. 5C, the blood cell component 21b is pushed up above the cup portion of the separation float through the communicating hole by depressing the separation float next. By collecting this blood cell component layer with the analysis nozzle, collection and measurement of the two components of blood become possible.
 (2)分離精度の同等性
 分離された血漿成分21aの吸上げの際、血漿成分21aと血球成分21bとは完全に分離されており、血漿成分21a中に血球成分21bが混入するおそれがないので、血液検査の精度は従来の検査と同等の精度を維持することができる。
 血漿成分21aの吸上げの際、分離フロートの上面が半球面状に切欠されているから、分析用のノズルをカップ部のどこに入れてもカップ部の上面に衝突するおそれがなく、血漿成分21aの採取を安定的かつ確実にすることができる。
(2) Equivalence of separation accuracy At the time of suction of the separated plasma component 21a, the plasma component 21a and the blood cell component 21b are completely separated, and there is no possibility that the blood cell component 21b is mixed in the plasma component 21a. Therefore, the accuracy of the blood test can maintain the same accuracy as the conventional test.
Since the upper surface of the separation float is cut like a hemispherical surface when drawing up the plasma component 21a, there is no possibility of colliding with the upper surface of the cup portion even if the analysis nozzle is inserted anywhere in the cup portion, and the plasma component 21a Collection can be stable and reliable.
 また血漿成分21aと血球成分21bとが確実に分離されるため、微量な血液量であっても、従来の検査と同等の精度で血液検査をすることができる。 In addition, since the blood plasma component 21a and the blood cell component 21b are reliably separated, it is possible to conduct a blood test with the same accuracy as in the conventional test, even with a small amount of blood.
 (3)自己採血可能性、取扱容易性、採血微量性
 分離フロートの上面が半球面状に切欠されているから、連通孔を相対的に短小化することができ、血球成分21bの採取が容易となる効果がある。
 また、採血ボトルへの採血は手指に図示しない穿刺具を穿刺することにより行うところ、採血は毛細血管から流出する血液を微量採取するため、神経の損傷や切断のおそれがなく、自己採血もリスクなく行うことができる。
(3) Self blood collection possibility, ease of handling, blood collection traceability Since the upper surface of the separation float is cut into a hemispherical shape, the communicating hole can be relatively shortened and collection of the blood cell component 21 b is easy. There is an effect that
In addition, blood is collected into a blood collection bottle by puncturing a finger with a puncture tool (not shown). However, blood collection involves collecting a small amount of blood flowing out from capillaries, so there is no risk of nerve damage or breakage, and self blood collection is also a risk. It can be done without.
(A)は本願発明による血液分離用容器の実施の形態を示す正面図、(B)は(A)の平面図、(C)は(A)のC-C断面図、(D)は(C)のD部拡大図である。(A) is a front view showing an embodiment of a blood separation container according to the present invention, (B) is a plan view of (A), (C) is a cross-sectional view taken along the line CC of (A), (D) is It is the D section enlarged view of C). (A)は図1の検査ボトルの正面図、(B)は(A)の平面図、(C)は(A)のC-C断面図、(D)は(B)のD-D断面図である。(A) is a front view of the inspection bottle of FIG. 1, (B) is a plan view of (A), (C) is a cross-sectional view taken along the line CC of (A), and (D) is a cross-section taken along line DD of (B) FIG. (A)は図1の分離フロートの正面図、(B)は(A)の平面図、(C)は(A)の底面図、(D)は(A)のD-D断面図、(E)は(A)の斜視図、(F)は(D)のF部拡大図である。(A) is a front view of the separation float of FIG. 1, (B) is a plan view of (A), (C) is a bottom view of (A), (D) is a DD sectional view of (A), E) is a perspective view of (A), (F) is an enlarged view of an F part of (D). (A)図1の採血ノズルの正面図、(B)は(A)の底面図、(C)は(A)の平面図、(D)は(A)のD-D断面図、(E)は(B)のE-E断面図である。(A) Front view of the blood collection nozzle of FIG. 1, (B) is a bottom view of (A), (C) is a plan view of (A), (D) is a cross-sectional view taken along DD of (A), (E ) Is an EE sectional view of (B). (A)は本願発明による血液分離用容器の使用方法を示す第1ステップの概略断面図、(B)は同第2ステップの概略断面図、(C)は同第3ステップの概略断面図である。(A) is a schematic cross-sectional view of a first step showing a method of using the blood separating container according to the present invention, (B) is a schematic cross-sectional view of the second step, (C) is a schematic cross-sectional view of the third step. is there. (A)は本願発明による血液分離用容器による血漿成分の吸上げ例を示す概略断面図、(B)は対比例による血漿成分の吸上げ例を示す概略断面図である。(A) is a schematic sectional drawing which shows the example of suction of the plasma component by the container for blood separation by this invention, (B) is a schematic sectional drawing which shows the example of suction of the plasma component by a comparative example. TPの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of TP. ALBの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of ALB. ASTの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of AST. ALTの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of ALT. γーGTPの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger-head blood and venous blood of (gamma) -GTP. BUNの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of BUN. CREAの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of CREA. UAの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of UA. T-CHOの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of T-CHO. HDL-Cの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of HDL-C. LDL-Cの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of LDL-C. TGの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of TG. CRPの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of CRP. HbA1cの指頭血と静脈血との相関を示すグラフである。It is a graph which shows correlation with finger blood and venous blood of HbA1c.
 次に、実施の形態を示す図面に基づき本願発明による血液検査用器具をさらに詳しく説明する。なお、便宜上同一の機能を奏する部分には同一の符号を付してその説明を省略する。図1は本願発明による血液検査用器具に採血のための採血ノズルを組み込んだ状態を示す。 Next, the blood test instrument according to the present invention will be described in more detail based on the drawings showing the embodiment. For the sake of convenience, the same reference numerals are given to parts that perform the same function, and the descriptions thereof will be omitted. FIG. 1 shows a blood test device according to the present invention in which a blood collection nozzle for blood collection is incorporated.
 1は採血ボトルであり、先端部3が開放された有底の筒状容器からなる。図2は採血ボトル1の詳細を示し、5は該採血ボトル1の底部であり、凹弧状の底面5aを有し、かつ、基端部が外方に延長され脚部5bを形成する。上記先端部3には着脱自在の蓋部4が設けられる。上記採血ボトル1内に分離フロート7が移動可能に収容される。 Reference numeral 1 denotes a blood collection bottle, which comprises a bottomed cylindrical container in which the tip 3 is opened. FIG. 2 shows the details of the blood collection bottle 1, 5 being the bottom of the blood collection bottle 1 having a concave arc shaped bottom 5a and having its proximal end extended outwardly to form a leg 5b. The tip 3 is provided with a removable lid 4. A separation float 7 is movably accommodated in the blood collection bottle 1.
 図3は分離フロート7の詳細を示す。即ち、分離フロート7は、上面に半球面状(図示実施例では断面半正円形)に切欠されてなるカップ部9が形成され、このカップ部9にて採取された血液21(図5に示す)を受ける。また上記分離フロート7の中心部には連通孔11が設けられ、該連通孔11にて上記カップ部9と採血ボトル1の底面5aとが連通される。
 上記連通孔11は、採血ボトル1の底部側の開口面が拡大され、ここに拡大孔13が形成される。上記連通孔11の拡大孔13の周壁13aは図3(F)に示すように、凹弧状に形成される。
FIG. 3 shows the details of the separating float 7. That is, the separation float 7 is formed on the upper surface thereof with a cup portion 9 cut in a hemispherical shape (in the illustrated embodiment, a semicircular cross section in the illustrated embodiment), and the blood 21 collected by this cup portion 9 (shown in FIG. ). Further, a communication hole 11 is provided at the central portion of the separation float 7, and the cup portion 9 and the bottom surface 5 a of the blood collection bottle 1 are communicated with each other through the communication hole 11.
In the communication hole 11, the opening surface on the bottom side of the blood collection bottle 1 is enlarged, and the enlarged hole 13 is formed here. The peripheral wall 13a of the enlarged hole 13 of the communication hole 11 is formed in a concave arc shape as shown in FIG. 3 (F).
 上記採血ボトル1の内周壁1bの中間部付近には、当初、図1(D)の一点鎖線Cに示すように、比重を分断フロート7より若干大としたゲル状の分離剤16aが帯状に塗布される。 In the vicinity of the middle portion of the inner peripheral wall 1b of the blood collection bottle 1, a gel-like separating agent 16a having a specific gravity slightly larger than that of the float 7 is initially formed in a band shape as shown in FIG. It is applied.
 17は採血ノズルであり、採血ボトル1の先端部3に着脱自在に嵌着される。該採血ノズル17は、図4に示すように、両端が開放され、先端部17aに向かってテーパ状に形成され、採血ボトル1に着脱自在に嵌着される基端部17bには、圧力調整のための圧力調整溝18が形成される。 Reference numeral 17 denotes a blood collection nozzle, which is detachably fitted to the front end portion 3 of the blood collection bottle 1. As shown in FIG. 4, the blood collection nozzle 17 is open at both ends, is formed in a tapered shape toward the tip end portion 17 a, and pressure adjustment is performed on the proximal end portion 17 b detachably fitted to the blood collection bottle 1. The pressure control groove 18 for the is formed.
 上記採血ボトル1、分離フロート7及び採血ノズル17はいずれもプラスチックからなる。 The blood collection bottle 1, the separation float 7, and the blood collection nozzle 17 are all made of plastic.
 上記分離フロート7は、使用前においては、上記採血ボトル1の内周壁1bの長手方向中間部に半固定状態にて位置する。これは、当初塗布されるゲル状の分離剤16aの粘着性によるためである。 The separation float 7 is positioned in a semi-fixed state at a longitudinally intermediate portion of the inner peripheral wall 1 b of the blood collection bottle 1 before use. This is because of the tackiness of the gel-like separating agent 16a that is initially applied.
 また採血の際、図4に示す採血ノズル17を用いる場合には、図1に示すように採血ノズル17が採血ボトル1の先端部3に着脱自在に嵌着される。この場合、図示しない抗凝固剤が採血ノズル17の内周壁17c及び採血ボトル1の上部内周壁1aに噴霧され、使用の際には乾燥状態となっている。 When blood collection nozzle 17 shown in FIG. 4 is used at the time of blood collection, blood collection nozzle 17 is detachably fitted to tip portion 3 of blood collection bottle 1 as shown in FIG. In this case, an anticoagulant (not shown) is sprayed on the inner peripheral wall 17c of the blood collection nozzle 17 and the upper inner peripheral wall 1a of the blood collection bottle 1, and is in a dry state at the time of use.
 次に採血について説明する。ユーザ(一般人又は医療関係者)が、図示しない穿刺具にて、手の指から微量の血液を採取する。採血された血液21は、採血ノズル17より採血ボトル1内に流入すると、採血ノズル17及び採血ボトル1の内面に抗凝固剤が塗布されているため、図5(A)に示すように、凝血しない状態で血液分析センターに運搬されてくる。 Next, blood collection will be described. A user (general person or medical staff) collects a small amount of blood from the finger of the hand with a puncture device not shown. When the blood 21 collected is flowed into the blood collection bottle 1 from the blood collection nozzle 17, an anticoagulant is applied to the inside of the blood collection nozzle 17 and the inner surface of the blood collection bottle 1, as shown in FIG. It is transported to the blood analysis center without doing anything.
 血液21は血液分析センターにて遠心分離されると、血液成分が上層と下層に分離され、図5(B)に示すように、分離フロート7の上部に血漿成分21aが、分離フロート7の下方即ち採血ボトル1の底部5に血球成分21bが溜まる。 When blood 21 is centrifuged at the blood analysis center, the blood components are separated into upper and lower layers, and as shown in FIG. 5 (B), plasma component 21a at the top of separation float 7 and below separation float 7 That is, the blood cell component 21b is accumulated in the bottom 5 of the blood collection bottle 1.
 ここで、血液21が血漿成分21aと血球成分21bに分離されるときについて詳しく述べる。採血ボトル1の内周壁1bに帯状に付与されているゲル状の分離剤16aは、分離フロート7を回転させながら採血ボトル1内に挿入することにより、分離フロート7の外周壁7aと採血ボトル1の内周壁1bの間に均一に塗布されるので、まず、この分離フロート7の外周壁7aと採血ボトル1の内周壁1bとの間をシーリングする。この状態で血液21を遠心分離をすると、比重の大きい血球成分21bが連通孔11より底部5に落下する。このとき、各部の比重差により、図5(B)に示すように、上から順に血漿成分21a、分離フロート7、分離剤16b、血球成分21bと層状に位置する。なお、分離フロート7の挿入により分離フロート7の外周壁7aと採血ボトル1の内周壁1bとの間に進入してきている分離剤16aは、遠心分離の終了の頃になると、段々と落下が納まり、その粘着力により中心方向に集まって最終的には連続され、分離フロート7の底面7bにおいて層状の分離剤16bとなる。この分離剤16bにより分離フロート7の拡大孔13及び連通孔11が閉塞される。
 このシーリング効果により、採血ボトル1内の上層には斜線で示す血漿成分21aが、下層にはクロス斜線で示す血球成分21bが分離生成される。
Here, the time when the blood 21 is separated into the plasma component 21a and the blood cell component 21b will be described in detail. The gel-like separation agent 16a applied in a band shape to the inner peripheral wall 1b of the blood collection bottle 1 is inserted into the blood collection bottle 1 while rotating the separation float 7, whereby the outer peripheral wall 7a of the separation float 7 and the blood collection bottle 1 First, the space between the outer peripheral wall 7a of the separation float 7 and the inner peripheral wall 1b of the blood collection bottle 1 is sealed. When the blood 21 is centrifuged in this state, the blood cell component 21 b having a large specific gravity drops from the communication hole 11 to the bottom 5. At this time, due to the specific gravity difference of each part, as shown in FIG. 5 (B), the blood plasma component 21a, the separation float 7, the separating agent 16b, and the blood cell component 21b are layered sequentially from the top. The separation agent 16a entering between the outer peripheral wall 7a of the separation float 7 and the inner peripheral wall 1b of the blood collection bottle 1 by the insertion of the separation float 7 gradually falls when the end of the centrifugal separation is reached. The adhesive force gathers in the central direction and finally continues to form a layered separating agent 16 b at the bottom 7 b of the separating float 7. The enlarged hole 13 and the communicating hole 11 of the separation float 7 are closed by the separating agent 16 b.
Due to this sealing effect, the blood plasma component 21a shown by hatching is separated and generated in the upper layer in the blood collection bottle 1, and the blood cell component 21b shown in cross hatching is separated and generated in the lower layer.
 そこで遠心分離した上清の血漿成分21aを採取した後、次に、分離フロート7をAの位置(図5(B)に示す)からBの位置(図5(C)に示す)に押し下げることにより、その押下げ圧により分離剤16bがカップ部9内に除去されるので、血球成分21bが連通孔11を通じ分離フロート7のカップ部9上方に押し上げられ、この血球成分層を分析用ノズル19で採取することで、血液2成分の採取測定が可能となる。 Therefore, after collecting the plasma component 21a of the centrifuged supernatant, the separation float 7 is then pushed from the position of A (shown in FIG. 5 (B)) to the position of B (shown in FIG. 5 (C)). Since the separating agent 16b is removed into the cup portion 9 by the pressing pressure, the blood cell component 21b is pushed up above the cup portion 9 of the separation float 7 through the communication hole 11, and this blood cell component layer is subjected to the analysis nozzle 19 Collecting and measuring the two components of blood becomes possible.
 次に、分離された血漿成分21aは、分析用ノズル19により吸上げられ、図示しない自動分析機により所定の検査がなされる。この吸上げの際、血漿成分21aと血球成分21bとは完全に分離されており、血漿成分21a中に血球成分21bが混入するおそれがないので、血液検査の精度は従来の検査と同等の精度を維持することができる。 Next, the separated plasma component 21a is sucked by the analysis nozzle 19 and subjected to a predetermined test by an automatic analyzer (not shown). Since the blood plasma component 21a and the blood cell component 21b are completely separated at the time of this suction and there is no possibility that the blood cell component 21b is mixed in the blood plasma component 21a, the accuracy of the blood test is equivalent to that of the conventional test. Can be maintained.
 この点に関し、カップ部9’の内周面9aが図6(B)に示すように円錐面状であると、自動分析機の分析用ノズル19がカップ部9’の内周面9aに衝突することがあり、かかる場合血球成分21bが混入するため、正確な分析をすることができない。分析用ノズル19がカップ部の内周面に衝突すると、分離フロート7を押し下げることになり、下層の血球成分21bを押し上げるため、血球が混入してしまうからである。 In this regard, if the inner peripheral surface 9a of the cup portion 9 'is conical as shown in FIG. 6B, the analysis nozzle 19 of the automatic analyzer collides with the inner peripheral surface 9a of the cup portion 9'. In such a case, the blood cell component 21b is mixed, so that accurate analysis can not be performed. When the analysis nozzle 19 collides with the inner peripheral surface of the cup portion, the separation float 7 is pushed down, and the blood cell component 21b of the lower layer is pushed up, so that blood cells are mixed.
 これに対し本実施の形態においては、分析用ノズル19が図5(B)に示すようなカップ部9の適性位置(中央部付近)ではなく、図6(A)に示すようなカップ部9の不適性位置(偏心位置)に位置したとしても、カップ部9が半球面状に形成されているためカップ部9のどの位置であっても等距離となるから、下層の血球成分21bを押し上げることにならず、血球成分21b混入のおそれがないので、血漿成分21aの採取を安定的かつ確実にすることができるのである。 On the other hand, in the present embodiment, the analysis nozzle 19 is not at the suitable position (near the center) of the cup portion 9 as shown in FIG. 5B, but the cup portion 9 as shown in FIG. Even if it is positioned at the improper position (eccentric position), the cup portion 9 is formed in a hemispherical shape, and the blood cell component 21b in the lower layer is pushed up because it is equidistant at any position of the cup portion 9. In addition, since there is no risk of contamination of the blood cell component 21b, the collection of the plasma component 21a can be made stable and reliable.
 また、分離フロート7は、カップ部9の内周面9aが半球面状に切欠されているから、連通孔11を相対的に短小化することができ、血球成分21bの採取が容易となる効果がある。これは、連通孔11が長大化すると、血球成分21b採取の際、分離フロート7の押下げ距離が長大化するので、血球成分21bの採取が困難となるからである。 Further, in the separation float 7, since the inner peripheral surface 9a of the cup portion 9 is cut in a hemispherical shape, the communication hole 11 can be relatively shortened, and the blood cell component 21b can be easily collected. There is. This is because when the communication hole 11 is elongated, the pressing distance of the separation float 7 becomes longer at the time of collecting the blood cell component 21b, so that the collection of the blood cell component 21b becomes difficult.
 上記において、上記カップ部9が断面半楕円形であって、長軸が採血ボトルの長手方向に形成される場合は、図6で述べた血球成分21b混入のおそれがさらに防止され、また連通孔11の相対的短小化もさらに向上するので望ましい。 In the above, when the cup 9 is semi-elliptical in cross section and the major axis is formed in the longitudinal direction of the blood collection bottle, the risk of contamination of the blood cell component 21b described in FIG. It is desirable because the relative shortening of 11 may be further improved.
 さらに本実施の形態による血液検査用器具によれば、採血ボトル1の採血は、手指に図示しない穿刺具を穿刺することにより行うところ、採血は毛細血管から流出する血液を採取するため、微量であり、かつ神経の損傷や切断のおそれがなく、自己採血もリスクなく行うことができる。 Furthermore, according to the blood test instrument according to the present embodiment, the blood collection of the blood collection bottle 1 is performed by puncturing a finger with a puncture tool (not shown). Yes, there is no risk of nerve damage or amputation, and self-collection can be performed without risk.
 また血漿成分21aと血球成分21bとが確実に分離されるため、例えば150μl程度という微量な血液量であっても、従来の検査と同等の精度で血液検査をすることができる。なお、「150μl」の採血は再検分を確保した量である。 In addition, since the blood plasma component 21a and the blood cell component 21b are reliably separated, it is possible to conduct a blood test with the same accuracy as the conventional test, even if the blood volume is as small as about 150 μl, for example. In addition, "150 μl" of blood collection is an amount securing the re-inspection.
 ここで血液検査の高精度性について説明する。血液検査の高精度性については、第3者機関による評価がある。自治医科大学附属さいたま医療センター臨床検査部(尾本きよか教授、藤野真治技師長、渡野達朗副技師長)による報告書「多機能微量採血管による指頭血と注射針による静脈血とのデータ比較」である。この報告書の検査項目、検査材料の準備、使用試薬と分析装置及び結果は次の通りである。 Here, the high accuracy of the blood test will be described. There is an evaluation by a third party organization about the high accuracy of the blood test. Report by the Clinical Examination Department, Saitama Medical Center, Jichi Medical University (Prof. Kiyoka Omoto, Chief Engineer Fujino Shinji, Deputy Chief Engineer Tatsuro Watano) “Comparison of data between digital blood with multi-functional micro blood collection tube and venous blood with injection needle ". The inspection items of this report, preparation of inspection materials, reagents used and analyzers and results are as follows.
 <検査項目>
 特定検査項目を含む14項目
 TP・ALB・AST・ALT・γーGTP・BUN・CREA・UA・T-CHO・HDL-C・LDL-C・TG・CRP・HbA1c
<Inspection item>
14 items including specific test items TP · ALB · AST · ALT · γ-GTP · BUN · CUN · UA · T-CHO · HDL-C · LDL-C · TG · CRP · HbA1 c
 <検査材料の準備>
 1)採血方法
  採血は、対比試験用の静脈血を生化学採血管に3ml、EDTA採血管(HbA1c用)に2ml採血した後、速やかにマニュアルに従って本願発明による指頭血を採取した。
 2)検査前準備
  1)で採血した検体を生化学採血管については、3400rpm7分、EDTA採血管については、2050rpm5分で遠心分離し、得られた血糖、血漿を検査に供した。
<Preparation of inspection material>
1) Blood Collection Method Blood collection was carried out by collecting 3 ml of venous blood for comparison test in a biochemical blood collection tube and 2 ml in an EDTA blood collection tube (for HbA1c), and quickly collected finger head blood according to the present invention according to the manual.
2) Preparation before test The blood samples collected in 1) were centrifuged at 3400 rpm for 7 minutes for biochemical blood collection tubes and at 2050 rpm for 5 minutes for EDTA blood collection tubes, and the obtained blood glucose and plasma were subjected to a test.
 <使用試薬と分析装置>
  測定試薬の一覧を表1に示す。測定にはHbA1c以外の項目を自動生化学分析装置(JCA・BM6070、日本電子)で、HbA1cは自動生化学分析装置(JCA・BM6050、日本電子)を用い酵素法で測定した。
<Use reagent and analyzer>
A list of measurement reagents is shown in Table 1. For measurement, items other than HbA1c were measured by an automatic biochemical analyzer (JCA.BM6070, JEOL), and HbA1c was measured by an enzymatic method using an automatic biochemical analyzer (JCA.BM6050, JEOL).
 <結果>
  各項目の指頭血と静脈血との相関を表2及び図7A乃至図7Nに示した。TPの相関係数は0.884と14項目中最も悪かったが、指頭血と静脈地測定値の平均値の差は1.3%程度とわずかであった。指頭血のTPは、静脈血より高値であった。指頭血は血漿血でありフィプリノゲン含有の差に起因したものと考える。いずれの項目もその測定値はほぼ回帰線上に収束しており、非常に有効な結果を示しており、判定を誤るようなケースは認められなかった。
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
<Result>
Table 2 and FIGS. 7A to 7N show the correlation between the finger blood and the venous blood of each item. The correlation coefficient of TP was the worst among 0.884 and 14 items, but the difference between the mean value of the finger head blood and the measured value of vein was as small as 1.3%. The TP of finger blood was higher than that of venous blood. It is believed that the finger blood is plasma blood and is due to the difference in fiprinogen content. The measured value of each item converged almost on the regression line, showing very effective results, and no case was found to be misjudged.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
 これによると、本願発明による血液検査は、従来方法より誤差要因が少なく、かつ分析結果が医療機関データとほぼ同等と評価された。また採血時のノズルへの血液吸い込みが極めて良好で、スムーズに採血可能であること、採血量も150~200μlと十分であること、一本の採血管から血漿と血球の測定が可能であること、検体取り違えによる過誤防止、省力化に貢献できる等、多大の評価を得た。よって、医療機関においても採血時の負担軽減、健康診断等での採血業務、検査業務に寄与し、医療用廃棄物の軽減により産業上、国民経済上の貢献効果は極めて大である。 According to this, the blood test according to the present invention has less error factors than the conventional method, and the analysis result is evaluated as almost equal to the medical institution data. In addition, blood suction into the nozzle at the time of blood collection is extremely good and blood collection can be smoothly performed, blood collection volume is also sufficient at 150 to 200 μl, and blood plasma and blood cells can be measured from one blood collection tube. , We have received a great deal of evaluation, such as contributing to the prevention of errors due to misclassification and labor saving. Therefore, the medical institution also contributes to the burden reduction at the time of blood collection, blood collection work for medical examinations and examination work, and the contribution to the industry and the national economy is extremely large by reducing medical waste.
 このように本実施の形態による血液検査用器具によれば、構造簡単で取扱容易、かつ、血液分離に際し確実なシーリング効果を奏することができる。 As described above, according to the blood test instrument according to the present embodiment, the structure is simple and easy to handle, and a reliable sealing effect can be obtained in blood separation.
 本願発明による血液検査用器具によれば、上記した実施の形態に制限されない。例えば、上記連通孔11の拡大孔13は、周壁を突弧状あるいは扁平状にすることができる。
 分離剤の付与は採血ボトル1の内周壁1bの中間位置に点状に付与されてもよい。また、分離フロート7の当初位置も採取される血漿成分21aと血球成分21bの量により変更することが許される。採血ノズル17の内周壁17cの形状は任意であり、中途に段差(図示省略)をつけてもよい。さらに分離フロート7の底面7bの形状を採血ボトル1の底部5の形状と同一に形成すれば、血球成分21bの採取に一層有利である。
 ユーザは医療関係者はもちろん、一般人であっても簡単に使用し取り扱うことができる。
 なお、段落0043以下の報告書の検査項目は、血液検査の高精度性について説明するためのものであり、本願発明による血液検査用器具の検査項目を限定するものではない。
The blood test instrument according to the present invention is not limited to the above embodiment. For example, the enlarged hole 13 of the communication hole 11 can have a circumferential wall shaped like an arc or flat.
The application of the separating agent may be applied in the form of dots at an intermediate position of the inner peripheral wall 1 b of the blood collection bottle 1. Further, the initial position of the separation float 7 is also allowed to be changed depending on the amount of the blood plasma component 21a and the blood cell component 21b to be collected. The shape of the inner peripheral wall 17c of the blood collection nozzle 17 is arbitrary, and a step (not shown) may be provided halfway. Furthermore, if the shape of the bottom surface 7b of the separation float 7 is the same as the shape of the bottom 5 of the blood collection bottle 1, it is more advantageous for the collection of the blood cell component 21b.
The user can be easily used and handled by medical personnel as well as general persons.
In addition, the examination item of the report after paragraph 0043 is for demonstrating the high precision of a blood test, and does not limit the examination item of the instrument for a blood test by this invention.
 本願発明による血液検査用器具によれば、血液検査に活用することができる。 The instrument for a blood test according to the present invention can be used for a blood test.
 1   採血ボトル
 1a  上部内周壁
 1b  内周壁
 3   先端部
 4   蓋部
 5   底部
 5a  底面
 5b  脚部
 7   分離フロート
 7a  外周壁
 7b  底面
 9   カップ部
 9’  カップ部
 9a  内周面
 11  連通孔
 13  拡大孔
 13a 周壁
 16a 分離剤
 16b 分離剤
 17  採血ノズル
 17a 先端部
 17b 基端部
 17c 内周壁
 18  圧力調整溝
 19  分析用ノズル
 21  血液
 21a 血漿成分
 21b 血球成分
DESCRIPTION OF SYMBOLS 1 blood collection bottle 1a upper inner peripheral wall 1b inner peripheral wall 3 tip 4 lid 5 bottom 5a bottom 5b leg 7 separation float 7a outer peripheral wall 7b bottom 9 cup part 9 'cup part 9a inner peripheral face 11 communication hole 13 enlarged hole 13a peripheral wall 16a separation agent 16b separation agent 17 blood collection nozzle 17a tip 17b proximal end 17c inner peripheral wall 18 pressure adjustment groove 19 analysis nozzle 21 blood 21a plasma component 21b blood component

Claims (11)

  1.  採血ボトルと分離フロートとからなる血液検査用器具であって、
     採血ボトルは先端部が開放された有底の筒状容器からなり、内周壁に分離剤が付与されてなり、
     分離フロートは上記採血ボトル内に移動可能に収容され、
     上記分離フロートには血液を受ける面が球面状に切欠されてなるカップ部が形成されるとともに、中心部に連通孔が設けられ、
     該連通孔にて上記カップ部と採血ボトルの底面とが連通され、
     上記連通孔は採血ボトルの底部側開口面が拡大して形成され、
     上記分離フロートの底部は上記採血ボトルの底部と同一形状に形成されることを特徴とする血液検査用器具。
    A blood test instrument comprising a blood collection bottle and a separation float, wherein
    The blood collection bottle consists of a bottomed cylindrical container whose tip is open, and a separating agent is applied to the inner peripheral wall,
    The separation float is movably accommodated in the blood collection bottle,
    The separation float is formed with a cup portion in which a surface for receiving blood is notched in a spherical shape, and a communication hole is provided in the central portion,
    The cup portion and the bottom surface of the blood collection bottle are communicated with each other through the communication hole,
    The communication hole is formed by enlarging the bottom side opening surface of the blood collection bottle,
    The bottom of the separation float is formed in the same shape as the bottom of the blood collection bottle.
  2.  請求項1記載の血液検査用器具において、上記カップ部が半球面状に形成されることを特徴とする血液検査用器具。 The blood test apparatus according to claim 1, wherein the cup portion is formed in a hemispherical shape.
  3.  請求項2記載の血液検査用器具において、上記カップ部が断面半正円形であることを特徴とする血液検査用器具。 The blood test apparatus according to claim 2, wherein the cup portion has a semicircular cross section.
  4.  請求項2記載の血液検査用器具において、上記カップ部が断面半楕円形であって、長軸が採血ボトルの長手方向に形成されることを特徴とする血液検査用器具。 The blood test apparatus according to claim 2, wherein the cup portion is semi-elliptical in cross section, and the major axis is formed in the longitudinal direction of the blood collection bottle.
  5.  請求項1乃至請求項4のいずれか一記載の血液検査用器具において、上記連通孔の拡大孔の周壁が凹弧状に形成されることを特徴とする血液検査用器具。 The blood test device according to any one of claims 1 to 4, wherein a peripheral wall of the enlarged hole of the communication hole is formed in a concave arc shape.
  6.  請求項1乃至請求項4のいずれか一記載の血液検査用器具において、上記連通孔の拡大孔の周壁が突弧状に形成されることを特徴とする血液検査用器具。 The blood test apparatus according to any one of claims 1 to 4, wherein the peripheral wall of the enlarged hole of the communication hole is formed in an arc shape.
  7.  請求項1乃至請求項4のいずれか一記載の血液検査用器具において、上記連通孔の拡大孔の周壁が扁平状に形成されることを特徴とする血液検査用器具。 The blood test apparatus according to any one of claims 1 to 4, wherein the peripheral wall of the enlarged hole of the communication hole is formed flat.
  8.  請求項1乃至請求項7のいずれか一記載の血液検査用器具において、上記分離剤が上記採血ボトルの内周壁の中間部に帯状に付与されることを特徴とする血液検査用器具。 The blood test apparatus according to any one of claims 1 to 7, wherein the separating agent is applied in a band shape to an intermediate portion of an inner peripheral wall of the blood collection bottle.
  9.  請求項1記載の血液検査用器具において、上記採血ボトルの上部の内周壁に抗凝固剤が付与されることを特徴とする血液検査用器具。 The blood test apparatus according to claim 1, wherein an anticoagulant is applied to the inner peripheral wall of the upper portion of the blood collection bottle.
  10.  請求項1記載の血液検査用器具において、上記分離フロートは当初上記採血ボトルの中間部に半固定状態にて位置することを特徴とする血液検査用器具。 The blood test apparatus according to claim 1, wherein the separation float is initially positioned in a semi-fixed state in the middle of the blood collection bottle.
  11.  請求項1記載の血液検査用器具において、上記採血ボトルの先端部に採血ノズルが着脱自在に嵌着され、該採血ノズルは両端が開放され、先端部に向かってテーパ状に形成され、採血ボトルに着脱自在に嵌着される基端部に、圧力調整のための圧力調整溝が形成されることを特徴とする血液検査用器具。 The blood test apparatus according to claim 1, wherein a blood collection nozzle is detachably fitted to the front end of the blood collection bottle, the blood collection nozzle is open at both ends, and is tapered toward the front end, the blood collection bottle A blood test instrument characterized in that a pressure control groove for pressure control is formed at a proximal end portion detachably fitted to the
PCT/JP2018/044070 2017-12-01 2018-11-29 Blood test container WO2019107509A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017232056A JP6480551B1 (en) 2017-12-01 2017-12-01 Blood test container
JP2017-232056 2017-12-01

Publications (1)

Publication Number Publication Date
WO2019107509A1 true WO2019107509A1 (en) 2019-06-06

Family

ID=65718167

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/044070 WO2019107509A1 (en) 2017-12-01 2018-11-29 Blood test container

Country Status (2)

Country Link
JP (1) JP6480551B1 (en)
WO (1) WO2019107509A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020138100A1 (en) * 2018-12-27 2020-07-02 ジャパン・メディカル・リーフ株式会社 Blood test apparatus
US11654428B2 (en) 2019-01-21 2023-05-23 Vias Partners, Llc Methods, systems and apparatus for separating components of a biological sample

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019101046A (en) * 2019-02-07 2019-06-24 ジャパン・メディカル・リーフ株式会社 Blood test container
WO2024024039A1 (en) * 2022-07-28 2024-02-01 ナッジヘルステック株式会社 Blood storage container and blood collection instrument

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4417981A (en) * 1981-05-04 1983-11-29 Becton, Dickinson And Company Blood phase separator device
JPH06222055A (en) * 1993-01-22 1994-08-12 Niigata Kako Kk Component separating member for liquid sample
JPH11318870A (en) * 1998-05-19 1999-11-24 Ir Medical:Kk Blood drawing tube and separation of serum and plasma utilizing the same
JP2002267660A (en) * 2001-03-09 2002-09-18 Sekisui Chem Co Ltd Vessel for inspecting blood
JP2007501398A (en) * 2003-08-05 2007-01-25 ベクトン・ディキンソン・アンド・カンパニー Apparatus and method for collection of biological fluid samples and treatment of selected components
JP2007271388A (en) * 2006-03-30 2007-10-18 Hidetoshi Tsuchida Separation method of serum or plasma, and blood separation tube
JP2010032447A (en) * 2008-07-31 2010-02-12 Panasonic Corp Immunochromatography measuring device
JP2015179038A (en) * 2014-03-19 2015-10-08 テルモ株式会社 Chip for measurement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74967A (en) * 1985-04-18 1988-10-31 Assaf Pharmaceutical Ind Separation of materials from a liquid dispersion by sedimentation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4417981A (en) * 1981-05-04 1983-11-29 Becton, Dickinson And Company Blood phase separator device
JPH06222055A (en) * 1993-01-22 1994-08-12 Niigata Kako Kk Component separating member for liquid sample
JPH11318870A (en) * 1998-05-19 1999-11-24 Ir Medical:Kk Blood drawing tube and separation of serum and plasma utilizing the same
JP2002267660A (en) * 2001-03-09 2002-09-18 Sekisui Chem Co Ltd Vessel for inspecting blood
JP2007501398A (en) * 2003-08-05 2007-01-25 ベクトン・ディキンソン・アンド・カンパニー Apparatus and method for collection of biological fluid samples and treatment of selected components
JP2007271388A (en) * 2006-03-30 2007-10-18 Hidetoshi Tsuchida Separation method of serum or plasma, and blood separation tube
JP2010032447A (en) * 2008-07-31 2010-02-12 Panasonic Corp Immunochromatography measuring device
JP2015179038A (en) * 2014-03-19 2015-10-08 テルモ株式会社 Chip for measurement

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020138100A1 (en) * 2018-12-27 2020-07-02 ジャパン・メディカル・リーフ株式会社 Blood test apparatus
US11654428B2 (en) 2019-01-21 2023-05-23 Vias Partners, Llc Methods, systems and apparatus for separating components of a biological sample

Also Published As

Publication number Publication date
JP6480551B1 (en) 2019-03-13
JP2019100858A (en) 2019-06-24

Similar Documents

Publication Publication Date Title
WO2019107509A1 (en) Blood test container
JP4796959B2 (en) Biological sample collection tool and biological sample collection method
US10080516B2 (en) Biological fluid collection device and biological fluid separation and testing system
JP5108503B2 (en) Assembly for collecting, processing and analyzing samples
US9808192B2 (en) Biological fluid sampling transfer device and biological fluid separation and testing system
JP6104480B2 (en) Sampling separation device
CN111133311B (en) Blood collection device
JP6836012B2 (en) Analyzer cartridge with capillary wiper
US20050267384A1 (en) Blood collection kit adapter
WO2020162261A1 (en) Blood separation container
JP2007167124A (en) Vacuum blood collection tube
WO2020138100A1 (en) Blood test apparatus
TWI828265B (en) Blood storage containers and blood collection equipment
Iwasawa et al. Correlation of the Blood Test Results Obtained between Assays Using Microliter-scale Fingertip Blood Samples Collected with a Novel Blood Collection Device and Conventional Venous Blood Assays: a Secondary Publication in English
TW202406525A (en) Blood storage containers and blood collection equipment
JP2023062899A (en) Blood storage container and blood collection instrument
JP5955478B2 (en) Body fluid collector
JP2015052459A (en) Biological fluid sampler
JP2002333442A (en) Plasma component separator and method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18883652

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18883652

Country of ref document: EP

Kind code of ref document: A1